Chapin Davis’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.53M | Buy |
1,961
+192
| +11% | +$150K | 0.42% | 56 |
|
|
2025
Q1 | $1.46M | Sell |
1,769
-83
| -4% | -$68.6K | 0.5% | 48 |
|
|
2024
Q4 | $1.64M | Hold |
1,852
| – | – | 0.54% | 42 |
|
|
2024
Q3 | $1.64M | Hold |
1,852
| – | – | 0.53% | 43 |
|
|
2024
Q2 | $1.68M | Sell |
1,852
-15
| -0.8% | -$13.6K | 0.57% | 39 |
|
|
2024
Q1 | $1.45M | Sell |
1,867
-3,232
| -63% | -$2.51M | 0.53% | 43 |
|
|
2023
Q4 | $2.97M | Buy |
5,099
+537
| +12% | +$313K | 1.25% | 16 |
|
|
2023
Q3 | $2.45M | Buy |
4,562
+2,676
| +142% | +$1.44M | 1.17% | 16 |
|
|
2023
Q2 | $884K | Buy |
1,886
+6
| +0.3% | +$2.81K | 0.42% | 63 |
|
|
2023
Q1 | $646K | Sell |
1,880
-7,635
| -80% | -$2.62M | 0.33% | 84 |
|
|
2022
Q4 | $3.48M | Buy |
+9,515
| New | +$3.48M | 2.02% | 5 |
|